中國恆大(03333.HK)急吐12%失守50天線 發盈警料中績少賺46%
中國恆大(03333.HK)發盈警料中績少賺46%,該股今早急降失守50天、10天及20天線(21.4-21.52元),最低見19.48元,現造19.66元,急吐12%,成交已有1,839萬股,涉資3.77億元。
恆大發盈警指,由於新冠肺炎爆發,公司進行全國促銷活動實施價格優惠,同時營銷費用上升,期間外匯匯率波動亦引起外匯虧損,附屬公司對新能源汽車投入引起合併報表錄得虧損,預計上半年核心業務淨利潤及淨利潤按年分別跌37%至193億元人民幣及跌46%至147億元人民幣,但環比仍分別增長86%及1.3倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.